- Presentations
- 6
- Markets
- 1
Promacta is a brand of Eltrombopag marketed by Novartis Pharmaceuticals, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Eltrombopag
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 12.5 mg powder for oral suspension, 25 mg powder for oral suspension, 12.5 mg tablet, 25 mg tablet, 50 mg tablet, 75 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Promacta 12.5 mg powder for oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Promacta 25 mg powder for oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Promacta 12.5 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Promacta 25 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Promacta 50 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Promacta 75 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Eltrombopag.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Promacta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.